Abstract:Objective:To explore the feasibility and indications of non-operative management for blunt liver injury.
Methods :The clinical data of 109 patients with blunt liver injury treated in recent 5 years were reviewed retrospectively.
Results:Among 109 cases, 35 were treated with nonoperation and 33（94.3 %） were cured; there were 3 cases(9.1 %) with complications among the 33 cases who were cured. The mean amount of blood transfusion, hospitalization days and expenses were （2.5±0.8）U，（13.2±1.3）d and （5 250±335） yuan, respectively. Seventy-four cases were treated with operation and 68（91.2 %）were cured, there were 14 cases (20.6 %) with complications among the 68 cases who were cured. The mean amount of blood transfusion,number of hospitalization days and expenses were (8.4±1.1)U，(15.4±0.9)d and (13 550±805) yuan,respectively.The mean amount of blood transfusion and hospitalization expenses of nonoperative group were lower than those of operative group (P＜0.05).
Conclusions:With earlier diagnosis, more intensive monitoring of blood dynamics, strict control of the indications of nonoperative treatment and close monitoring of changes of the liver injury, the nonoperative therapy for blunt hepatic trauma of stages Ⅰto Ⅲ is safe and feasible.